Skip to contentZOTH LOTA S — NEWLINK GENETICS CORP insider: 152 transactions · InsiderLensZOTH LOTA S
- Director at enGene Holdings Inc. · on record since Dec 19, 2023
- Director at Orexigen Therapeutics, Inc. · on record since Apr 30, 2012
- Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
- Director at FIRST FINANCIAL BANKSHARES INC · on record since May 5, 2026
- Director at NEWLINK GENETICS CORP · on record since Nov 6, 2012
- Director at INOVIO BIOMEDICAL CORP · on record since May 21, 2026
- Director at One e Commerce CORP · on record since Jan 8, 2016
- SVP & Chief Financial Officer at MEDIMMUNE INC /DE · on record since Feb 18, 2005
- Director at Zymeworks Inc. · on record since Jan 2, 2019
- CHIEF SCIENTIFIC OFFICER at One e Commerce CORP · on record since Dec 17, 2019
- Director at 89bio, Inc. · on record since Jun 16, 2020
Insider trading activity of ZOTH LOTA S
- Transactions on record
- 152
- since Mar 10, 2004
- Open-market buys
- 0
- Open-market sells
- 7
- $84K
- Companies traded
- 10
- last filing Jun 17, 2026
Figures computed from official regulatory filings — methodology.
Companies where ZOTH LOTA S has traded
- enGene Holdings Inc.4 tx · Jun 17, 2026
- INOVIO BIOMEDICAL CORP39 tx · $37.8K · May 21, 2026
- FIRST FINANCIAL BANKSHARES INC1 tx · May 5, 2026
- 89bio, Inc.12 tx · Oct 30, 2025
- NEWLINK GENETICS CORP47 tx · Dec 13, 2024
- Zymeworks Inc.4 tx · Dec 23, 2022
- One e Commerce CORP15 tx · $343.5K · Dec 17, 2019
- Orexigen Therapeutics, Inc.7 tx · Jul 18, 2017
- HYPERION THERAPEUTICS INC9 tx · $1.8M · May 8, 2015
Track record of ZOTH LOTA S
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of ZOTH LOTA S
Co-insiders of ZOTH LOTA S
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
14 tx · $46.2K · Jun 19, 2007
AKKARAJU SRINIVASOne e Commerce CORP
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 17, 2026 | AwardD | 31,000 | 0.00 USD | — | SEC |
| May 21, 2026 | AwardD | 34,200 | 0.00 USD | $0 | SEC |
| May 21, 2026 | AwardD | 41,800 | 0.00 USD | $0 | SEC |
| May 5, 2026 | Award | 2,142 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -12,500 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -27,400 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -20,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -25,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -45,150 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -56,400 | 0.00 USD | $0 | SEC |
| Jun 16, 2025 | AwardD | 22,500 | 0.00 USD | $0 | SEC |
| May 21, 2025 | ExerciseD | -2,167 | 0.00 USD | $0 | SEC |
| May 21, 2025 | Exercise | 2,167 | — | — | SEC |
| Feb 5, 2025 | AwardD | 56,400 | 0.00 USD | $0 | SEC |
| Dec 13, 2024 | OtherD | -2,910 | — | — | SEC |
| Dec 13, 2024 | OtherD | -2,777 | — | — | SEC |
| Dec 13, 2024 | OtherD | -5,324 | — | — | SEC |
| Dec 13, 2024 | OtherD | -3,345 | — | — | SEC |
| Dec 13, 2024 | OtherD | -3,328 | — | — | SEC |
| Dec 13, 2024 | Other | -2,187 | — | — | SEC |
| Dec 13, 2024 | OtherD | -5,684 | — | — | SEC |
| Dec 13, 2024 | OtherD | -3,431 | — | — | SEC |
| Jun 18, 2024 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | AwardD | 3,328 | 0.00 USD | $0 | SEC |
| May 22, 2024 | AwardD | 2,167 | 0.00 USD | $0 | SEC |